Fundz

Fundz Deep Dive

Everything you need to win InhaleRx — in one platform.

Who to reach, what to say, and why now on InhaleRx — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on InhaleRx — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Clendon Biotech Capital Partners with InhaleRx for $38.5 Million Funding

Oct 20, 2024•over 1 year ago

Contract Type

partnership

Biotechnology

Description

Biotechnology company InhaleRx has secured $38.5 million in funding from Clendon Biotech Capital to further develop its precision medicines delivered via inhalation. The partnership will cover all direct costs associated with the Phase 1 & 2 clinical development of its key drug development projects – IRX-211 and IRX-616a, targeting breakthrough cancer pain and panic disorder relief.

Company Information

Company

InhaleRx

About

InhaleRx is a biotechnology company specializing in precision medicines delivered via inhalation.

Predictive Intelligence
Strategic

ML-powered predictions for InhaleRx's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.